Publicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (99)

2024

  1. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Frontiers in Neurology , Vol. 15

2023

  1. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 110

  2. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

    European Archives of Psychiatry and Clinical Neuroscience

  3. Assessment of Upper Extremity Function in Multiple Sclerosis: Feasibility of a Digital Pinching Test

    JMIR Formative Research, Vol. 7

  4. Association of Early Progression Independent of Relapse Activity with Long-term Disability after a First Demyelinating Event in Multiple Sclerosis

    JAMA Neurology, Vol. 80, Núm. 2, pp. 151-160

  5. Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology

    Alzheimer's and Dementia, Vol. 19, Núm. 9, pp. 3815-3825

  6. Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease

    Neurobiology of Disease, Vol. 188

  7. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

    Neurology, Vol. 100, Núm. 23, pp. E2386-E2397

  8. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  9. Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts

    Alzheimer's Research and Therapy, Vol. 15, Núm. 1

  10. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders

    Brain Sciences, Vol. 13, Núm. 2

  11. Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis

    Annals of Neurology

  12. Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1624-1636

  13. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study

    The Lancet Neurology, Vol. 22, Núm. 12, pp. 1150-1159

  14. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014

  15. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1913-1924

  16. Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort

    Alzheimer's and Dementia

2022

  1. A smartphone sensor-based digital outcome assessment of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 28, Núm. 4, pp. 654-664

  2. An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort

    Neurology, Vol. 99, Núm. 12, pp. E1299-E1313

  3. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402